Skip to main content

Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.

Publication ,  Journal Article
Lazo de la Vega, L; Samaha, MC; Hu, K; Bick, NR; Siddiqui, J; Hovelson, DH; Liu, C-J; Carter, CS; Cho, KR; Sciallis, AP; Tomlins, SA
Published in: Molecular cancer research : MCR
March 2019

The molecular events driving low-grade endometrioid endometrial carcinoma (LGEC) development-like in many cancers-are incompletely understood. Hence, here we performed multiregion, comprehensive somatic molecular profiling of routinely processed formalin-fixed, paraffin-embedded (FFPE) material from 13 cases of LGEC totaling 64 minute, spatially defined cell populations ranging from presumed precursor lesions through invasive LGEC. Shared driving PTEN, PIK3R1, or PIK3CA mutations support clonal origin of the samples in each case, except for two cases with two clonally distinct neoplastic populations, consistent with unexpected multiclonality in LGEC development. Although substantial heterogeneity in driving somatic alterations was present across populations in nearly all cases, these alterations were usually clonal in a given population, supporting continued selection and clonal sweeping of driving alterations in populations with both precursor and LGEC histology. Importantly, CTNNB1 mutational status, which has been proposed as both prognostic and predictive in LGEC, was frequently heterogeneous and subclonal, occurring both exclusively in precursor or cancer populations in different cases. Whole-transcriptome profiling of coisolated RNA from 12 lesions (from 5 cases) was robust and confirmed histologic and molecular heterogeneity, including activated Wnt signaling in CTNNB1-mutant versus wild-type populations. Taken together, we demonstrate clinically relevant multiclonality and intratumoral heterogeneity during LGEC development with important implications for diagnosis, prognosis, and therapeutic prediction. More broadly, our methodology is broadly scalable to enable high-throughput genomic and transcriptomic characterization of precursor and invasive cancer populations from routine FFPE specimens. IMPLICATIONS: Multiregion profiling of LGEC populations using a highly scalable approach demonstrates clinically relevant multiclonality and intratumoral heterogeneity.

Duke Scholars

Published In

Molecular cancer research : MCR

DOI

EISSN

1557-3125

ISSN

1541-7786

Publication Date

March 2019

Volume

17

Issue

3

Start / End Page

731 / 740

Related Subject Headings

  • Paraffin Embedding
  • PTEN Phosphohydrolase
  • Oncology & Carcinogenesis
  • Neoplasm Grading
  • Mutation
  • Humans
  • Female
  • Endometrial Neoplasms
  • Developmental Biology
  • Class Ia Phosphatidylinositol 3-Kinase
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lazo de la Vega, L., Samaha, M. C., Hu, K., Bick, N. R., Siddiqui, J., Hovelson, D. H., … Tomlins, S. A. (2019). Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma. Molecular Cancer Research : MCR, 17(3), 731–740. https://doi.org/10.1158/1541-7786.mcr-18-1178
Lazo de la Vega, Lorena, Mia C. Samaha, Kevin Hu, Nolan R. Bick, Javed Siddiqui, Daniel H. Hovelson, Chia-Jen Liu, et al. “Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.Molecular Cancer Research : MCR 17, no. 3 (March 2019): 731–40. https://doi.org/10.1158/1541-7786.mcr-18-1178.
Lazo de la Vega L, Samaha MC, Hu K, Bick NR, Siddiqui J, Hovelson DH, et al. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma. Molecular cancer research : MCR. 2019 Mar;17(3):731–40.
Lazo de la Vega, Lorena, et al. “Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.Molecular Cancer Research : MCR, vol. 17, no. 3, Mar. 2019, pp. 731–40. Epmc, doi:10.1158/1541-7786.mcr-18-1178.
Lazo de la Vega L, Samaha MC, Hu K, Bick NR, Siddiqui J, Hovelson DH, Liu C-J, Carter CS, Cho KR, Sciallis AP, Tomlins SA. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma. Molecular cancer research : MCR. 2019 Mar;17(3):731–740.

Published In

Molecular cancer research : MCR

DOI

EISSN

1557-3125

ISSN

1541-7786

Publication Date

March 2019

Volume

17

Issue

3

Start / End Page

731 / 740

Related Subject Headings

  • Paraffin Embedding
  • PTEN Phosphohydrolase
  • Oncology & Carcinogenesis
  • Neoplasm Grading
  • Mutation
  • Humans
  • Female
  • Endometrial Neoplasms
  • Developmental Biology
  • Class Ia Phosphatidylinositol 3-Kinase